Teva Pharmaceutical Industries Ltd. has announced that the US Food and Drug Administration (FDA) has approved Austedo (deutetrabenazine) tablets for the treatment of chorea associated with Huntington's disease (HD), a rare and fatal neurodegenerative disorder. Teva Pharmaceutical Industries Ltd is headquartered in Israel.
Indications: Austedo is a vesicular monoamine transporter 2 (VMAT2) inhibitor indicated for the treatment of chorea associated with Huntington's disease.
Dosage/administration: The starting dose is 6 mg once daily; titrate up at weekly intervals by 6 mg per day to a tolerated dose that reduces chorea, up to a maximum recommended daily dosage of 48 mg (24 mg twice daily). Total daily dosages of ≥12 mg should be administered in 2 divided doses. Tablets should be administered with food and swallowed whole; they should not be chewed, crushed, or broken.
Adverse reactions: Most common adverse reactions were somnolence, diarrhea, dry mouth, and fatigue.
Teva announces FDA approval of AUSTEDO™ (deutetrabenazine) tablets for the treatment of chorea associated with Huntington’s disease. [news release]. Jerusalem, Israel: Teva Pharmaceutical Industries Ltd. April 3, 2017. http://www.tevapharm.com/news/teva_announces_fda_approval_of_austedo_deutetrabenazine_tablets_for_the_treatment_of_chorea_associated_with_huntington_s_disease_04_17.aspx. Accessed April 13, 2017.
This Week's Must Reads
Vitamin B12, Homocysteine Levels’ Effect on PD, Mov Disord; ePub 2018 Mar 6; Christine, et al
Gray Matter Volume Losses in ET Examined, Parkinsonism Relat Disord; ePub 2018 Mar 10; Cameron, et al
Impaired Set Shifting Linked with Previous Falls, Gait Posture; ePub 2018 Feb 28; McKay, et al
Pseudobulbar Affect Linked to Mood Symptoms in PD, J Neuropsychiatry Clin Neurosci; ePub 2018 Mar 5; Patel, et al
CV Comorbidities Common in Veterans with PD, J Parkinson Dis; ePub 2018 Feb 17; Kotagal, et al
Must Reads in FDA Actions
FDA Permits Marketing of Blood Test for Concussion, FDA news release; 2018 Feb 14
FDA Permits Marketing of Stroke Alert Software, FDA news release; 2018 Feb 13
Riptide Aspiration System Receives FDA Clearance, Medtronic news release; 2018 Jan 16
FDA Approves Vercise Deep Brain Stimulation System, Boston Scientific news release; 2017 Dec 11
FDA Approves Repatha to Prevent Stroke, Heart Attack, Amgen news release; 2017 Dec 1